Generic Ritalin, which is sold under the name Methylphenidate Hydrochloride tablets, is available in three different strengths: 5 mg, 10 mg, and 20 mg. Drug companies that currently manufacture the generic medication include Actavis Elizabeth, Watson Laboratories, and UCB, Inc. The U.S. Food and Drug Administration has given generic Ritalin products an "AB" rating, which means they are considered equivalent to the brand-name version.
Ritalin® (methylphenidate hydrochloride) is a prescription medication that has been licensed to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.
Ritalin was first manufactured by Novartis Pharmaceuticals. The patent has since expired, however, and generic Ritalin is now available.
Generic Ritalin is sold under the name Methylphenidate Hydrochloride tablets, and is available in the following strengths:
- Methylphenidate Hydrochloride 5 mg tablets
- Methylphenidate Hydrochloride 10 mg tablets
- Methylphenidate Hydrochloride 20 mg tablets.
Generic Ritalin is made by the following manufacturers:
- Mallinckrodt, Inc.
- UCB, Inc.
- Actavis Elizabeth
- Watson Laboratories.
All generic medications must have certain tests, comparing them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generic versions are equivalent to the brand-name medications and assigns a rating to each one. An "AB" rating means that the FDA has determined that a generic medication is equivalent to the brand-name version. All of the generic Ritalin versions currently available have an "AB" rating, meaning they should be equivalent to Ritalin.
However, generic medications are allowed to have different inactive ingredients from the brand-name medication. This might include fillers or dyes or other ingredients, which may cause problems for people with certain allergies or sensitivities.